A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects



Status:Terminated
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:May 2012
End Date:May 2013

Use our guide to learn which trials are right for you!

A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects

The purpose of this study is to compare the safety and effect of HPP404 versus placebo on
body weight in overweight or obese subjects.


Inclusion Criteria:

- Body Mass Index (BMI) from 30.0 to 39.9 kg/m2, for subjects with no additional co
morbidities;

- BMI from 27 to 39.9 kg/m2, for subjects with co morbidities (i.e. dyslipidemia
defined as high LDL (≥ 160 mg/dL) or high total cholesterol (≥ 240 mg/dL), or
subjects with hypertension)

Exclusion Criteria:

- Systolic blood pressure > 160 mmHg and/or diastolic pressure > 90 mmHg at the
Screening Visit without treatment

- History of use of tobacco or nicotine-containing products 180 days prior to Screening
visit

- Subjects with type 2 diabetes or fasting blood glucose concentration ≥ 126 mg/dL

- History of appetite or weight modifying surgeries/procedures
We found this trial at
10
sites
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Augusta, GA
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
High Point, NC
Click here to add this to my saved trials
?
mi
from
Hyannis, MA
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
?
mi
from
Richmond, VA
Click here to add this to my saved trials
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
?
mi
from
Valparaiso, IN
Click here to add this to my saved trials